Since our assay is designed to target INSM1 promoter activity, we anticipated the positive-hit compounds would be closely associated with the regulation of INSM1-promoter activity (epigenetic modification) and the subsequent interplay with N-Myc protein critical for NB survival. This evidence concerns the gene MYCN and neuroblastoma.